Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Robert S. Gable. (1993) Toward a Comparative Overview of Dependence Potential and Acute Toxicity of Psychoactive Substances Used Nonmedically. The American Journal of Drug and Alcohol Abuse 19:3, pages 263-281.
Read now
Read now
Articles from other publishers (64)
Alice Ameline, Morgane Baudry, Delphine Garnier, Jean-Sébastien Raul & Pascal Kintz. (2023) Case report of a fatal 3-hydroxyphencyclidine intoxication, including blood and hair results. Journal of Analytical Toxicology 47:6, pages 552-556.
Crossref
Crossref
Thomas Gilson, David Dolinak, Susan F. Ely & James R. Gill. 2023. Principles of Forensic Pathology. Principles of Forensic Pathology
339
374
.
Icro Maremmani, Matteo Pacini & Angelo G. I. MaremmaniIcro Maremmani, Matteo Pacini & Angelo G. I. Maremmani. 2023. Dual Disorder Heroin Addicts. Dual Disorder Heroin Addicts
109
163
.
Andrea de Bartolomeis, Licia Vellucci, Mark C. Austin, Giuseppe De Simone & Annarita Barone. (2022) Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics. Biomolecules 12:7, pages 909.
Crossref
Crossref
Vitor Silva Pereira & Vinícius Antonio Hiroaki-Sato. (2018) A brief history of antidepressant drug development: from tricyclics to beyond ketamine. Acta Neuropsychiatrica 30:6, pages 307-322.
Crossref
Crossref
H. Thomas MilhornH. Thomas Milhorn. 2018. Substance Use Disorders. Substance Use Disorders
143
153
.
Jason Wallach & Simon D. Brandt. 2018. New Psychoactive Substances. New Psychoactive Substances
261
303
.
Michael D.B. Swedberg. (2016) Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse. Journal of Pharmacological and Toxicological Methods 81, pages 295-305.
Crossref
Crossref
Michael D. B. Swedberg & Patrick Raboisson. (2014) AZD9272 and AZD2066: Selective and Highly Central Nervous System Penetrant mGluR5 Antagonists Characterized by Their Discriminative Effects. Journal of Pharmacology and Experimental Therapeutics 350:2, pages 212-222.
Crossref
Crossref
Michael D. B. Swedberg, Maria Ellgren & Patrick Raboisson. (2014) mGluR5 Antagonist-Induced Psychoactive Properties: MTEP Drug Discrimination, a Pharmacologically Selective Non–NMDA Effect with Apparent Lack of Reinforcing Properties. Journal of Pharmacology and Experimental Therapeutics 349:1, pages 155-164.
Crossref
Crossref
Margaret M. Stark & Guy A. Norfolk. 2011. Clinical Forensic Medicine. Clinical Forensic Medicine
357
399
.
B. Moghaddam & A.L. Pehrson. 2010. Advances in Schizophrenia Research 2009. Advances in Schizophrenia Research 2009
99
111
.
Steven Karch. 2008. Karch's Pathology of Drug Abuse, Fourth Edition. Karch's Pathology of Drug Abuse, Fourth Edition
574
607
.
Neal Benowitz, Brett Roth & Kent Olson. 2007. Addiction and the Medical Complications of Drug Abuse. Addiction and the Medical Complications of Drug Abuse
81
147
.
Neal Benowitz & Shoshana Zevin. 2007. Addiction and the Medical Complications of Drug Abuse. Addiction and the Medical Complications of Drug Abuse
47
79
.
Bita Moghaddam & Houman Homayoun. 2007. Handbook of Contemporary Neuropharmacology. Handbook of Contemporary Neuropharmacology.
Neal Benowitz. 2006. Drug Abuse Handbook, Second Edition. Drug Abuse Handbook, Second Edition
597
694
.
Joseph P. Pestaner & Pamela E. Southall. (2003) Sudden Death During Arrest and Phencyclidine Intoxication. American Journal of Forensic Medicine & Pathology 24:2, pages 119-122.
Crossref
Crossref
B. Moghaddam & J.H. Krystal. 2003. Schizophrenia. Schizophrenia
349
364
.
Barbara W. Adams, Charles W. Bradberry & Bita Moghaddam. (2002) NMDA antagonist effects on striatal dopamine release: Microdialysis studies in awake monkeys. Synapse 43:1, pages 12-18.
Crossref
Crossref
Barbara W. Adams & Bita Moghaddam. (2001) Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex. Biological Psychiatry 50:10, pages 750-757.
Crossref
Crossref
Margaret M. Stark & Guy Norfolk. 2000. A Physician’s Guide to Clinical Forensic Medicine. A Physician’s Guide to Clinical Forensic Medicine
179
219
.
Gaylord Ellison, Alan Keys & Kevin Noguchi. (2017)
Long‐Term Changes in Brain Following Continuous Phencyclidine Administration: An Autoradiographic Study using Flunitrazepam, Ketanserin, Mazindol, Quinuclidinyl benzilate, Piperidyl‐3,4‐
3
H(N)‐TCP, and AMPA Receptor Ligands
. Pharmacology & Toxicology 84:1, pages 9-17.
Crossref
Crossref
Teruo Hayashi, Tsung-Ping Su, Ariyuki Kagaya, Akira Nishida, Masami Shimizu & Shigeto Yamawaki. (1999) Neuroleptics with differential affinities at dopamine D2 receptors and sigma receptors affect differently the N-methyl-D-aspartate-induced increase in intracellular calcium concentration: Involvement of protein kinase. Synapse 31:1, pages 20-28.
Crossref
Crossref
Kap Lim, S. Michael Owens, Larry Arnold, James C. Sacchettini & D. Scott Linthicum. (1998) Crystal Structure of Monoclonal 6B5 Fab Complexed with Phencyclidine. Journal of Biological Chemistry 273:44, pages 28576-28582.
Crossref
Crossref
Una D. McCann, Kelly A. Lowe & George A. Ricaurte. (2016) REVIEW ■ : Long-lasting Effects of Recreational Drugs of Abuse on the Central Nervous System. The Neuroscientist 3:6, pages 399-411.
Crossref
Crossref
Kazuo Sakai, Kiyoshi Maeda, Shigeru Okuyama & Chikako Tanaka. (1996) Phencyclidine alters regional concentrations of neuropeptide Y and peptide YY in rat brain. Biological Psychiatry 40:12, pages 1246-1254.
Crossref
Crossref
G. D. Ellison & A. S. Keys. (1996) Persisting changes in brain glucose uptake following neurotoxic doses of phencyclidine which mirror the acute effects of the drug. Psychopharmacology 126:3, pages 271-274.
Crossref
Crossref
Rhea E. Steinpreis. (1996) The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Behavioural Brain Research 74:1-2, pages 45-55.
Crossref
Crossref
Gaylord Ellison. (1995) The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Research Reviews 20:2, pages 250-267.
Crossref
Crossref
S. M. LILLRANK, W. T. O'CONNOR, P. SARANSAARI & U. UNGERSTEDT. (1994) In vivo effects of local and systemic phencyclidine on the extracellular levels of catecholamines and transmitter amino acids in the dorsolateral striatum of anaesthetized rats. Acta Physiologica Scandinavica 150:2, pages 109-115.
Crossref
Crossref
Frank Owen & Michael Simpson. 1994. Molecular and Cell Biology of Neuropsychiatric Diseases. Molecular and Cell Biology of Neuropsychiatric Diseases
133
159
.
Xue-Min Gao, Osamu Shirakawa, Fu Du & Carol A. Tamminga. (1993) Delayed regional metabolic actions of phencyclidine. European Journal of Pharmacology 241:1, pages 7-15.
Crossref
Crossref
R.E. Steinpreis & J.D. Salamone. (1993) The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain Research 612:1-2, pages 263-270.
Crossref
Crossref
M.D.C. Simpson, P. Slater, M.C. Royston & J.F.W. Deakin. (1991) Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Schizophrenia Research 6:1, pages 41-48.
Crossref
Crossref
Paul J. Godley, Emory S. Moore, James R. Woodworth & Jerry Fineg. (2006)
Effects of ethanol and Δ
9
‐tetrahydrocannabinol on phencyclidine disposition in dogs
. Biopharmaceutics & Drug Disposition 12:3, pages 189-199.
Crossref
Crossref
Tadimeti S. Rao, Julie A. Cler, Steve J. Mick, Mark R. Emmett, John M. Farah, Patricia C. Contreras, Smriti Iyengar & Paul L. Wood. (1991) Neurochemical Interactions of Competitive N-Methyl-D-Aspartate Antagonists with Dopaminergic Neurotransmission and the Cerebellar Cyclic GMP System: Functional Evidence for a Phasic Glutamatergic Control of the Nigrostriatal Dopaminergic Pathway. Journal of Neurochemistry 56:3, pages 907-913.
Crossref
Crossref
W.Marvin Davis, Robert B. Hackett, Keith W. Obrosky & I.Wade Waters. (1991) Factors in the lethality of i.v. phencyclidine in conscious dogs. General Pharmacology: The Vascular System 22:4, pages 723-728.
Crossref
Crossref
J. Kornhuber, H. Beckmann & P. Riederer. 1991. Neurotransmitter und psychische Erkrankungen. Neurotransmitter und psychische Erkrankungen
147
157
.
Frank R. DePietro & James C. Byrd. (1990) Effects of membrane fluidity on [3H]TCP binding to PCP receptors. Journal of Molecular Neuroscience 2:1, pages 45-52.
Crossref
Crossref
George A. Palcos, Zan Wei Yang & James C. Byrd. (1990) Ontogeny of PCP and Sigma receptors in rat brain. Developmental Brain Research 51:2, pages 147-152.
Crossref
Crossref
Tadimeti S. Rao, Patricia C. Contreras & Paul L. Wood. (1990) Are N-methyl-d-aspartate (NMDA) and phencyclidine (PCP) receptors always functionally coupled to each other?. Neurochemistry International 17:1, pages 1-8.
Crossref
Crossref
J. Kornhuber, H. Beckmann & P. Riederer. 1990. Neuere Ansätze zur Diagnostik und Therapie schizophrener Minussymptomatik. Neuere Ansätze zur Diagnostik und Therapie schizophrener Minussymptomatik
119
126
.
J. Elks & C. R. Ganellin. 1990. Dictionary of Drugs. Dictionary of Drugs
928
1053
.
Loris D. McVittie & David R. Sibley. (1989) Solubilization of phencyclidine receptors from rat cerebral cortex in an active ligand binding state. Life Sciences 44:23, pages 1793-1802.
Crossref
Crossref
Arvind K. Chaturvedi & David J. Kuntz. (1988) Interaction between phencyclidine and its pyrolysis product, 1-phenylcyclohexene. Pharmacology Biochemistry and Behavior 30:4, pages 1035-1043.
Crossref
Crossref
Tomas J. Silber, Mariet Iosefsohn, Jocelyn M. Hicks, Pamela R. Getson & Regina O'DonnelL. (1988) Prevalence of PCP use among adolescent marijuana users. The Journal of Pediatrics 112:5, pages 827-829.
Crossref
Crossref
Mark S. Sonders, John F.W. Keana & Eckard Weber. (1988) Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action. Trends in Neurosciences 11:1, pages 37-40.
Crossref
Crossref
Joanne T. Adams, Peter M. Teal, Mark S. Sonders, Barbara Tester, Joseph S. Esherick, Michael W. Scherz, John F.W. Keana & Eckard Weber. (1987) Synthesis and characterization of an affinity label for brain receptors to psychotomimetic benzomorphans: differentiation of σ-type and phencyclidine receptors. European Journal of Pharmacology 142:1, pages 61-71.
Crossref
Crossref
William D. Wessinger. (1987) Behavioral dependence of phencyclidine in rats. Life Sciences 41:3, pages 355-360.
Crossref
Crossref
G. Ahmad, L.C. Halsall & S.C. Bondy. (1987) Persistence of phencyclidine in fetal brain. Brain Research 415:1, pages 194-196.
Crossref
Crossref
Roger L. Boeckx. (1987) Urine Drug Screening by Gas Chromatography–Mass Spectrometry: Application to a Pediatric Environment. Clinics in Laboratory Medicine 7:2, pages 401-414.
Crossref
Crossref
Michael R. Kozlowski, Ronald G. Browne & Fredric J. Vinick. (1986) Discriminative stimulus properties of phencyclidine (PCP)-related compounds: Correlations with 3H-PCP binding potency measured autoradiographically. Pharmacology Biochemistry and Behavior 25:5, pages 1051-1058.
Crossref
Crossref
Robert O. Messing & Roger P. Simon. (1986) Seizures as a Manifestation of Systemic Disease. Neurologic Clinics 4:3, pages 563-584.
Crossref
Crossref
Omanand Koul, James E. March, Raqhupathy Sarma, Cynthia Griffiths & Dale G. Deutsch. (2006) Effect of Phencyclidine on the Metabolism of Individual Brain Proteins. Journal of Neurochemistry 46:2, pages 470-474.
Crossref
Crossref
J. David Leander, C. Ray Wood, Dennis M. Zimmerman & Linda A. Dykstra. (2008) Phencyclidine‐ type catalepsy in the pigeon: An update on chen's work. Drug Development Research 7:1, pages 75-85.
Crossref
Crossref
B.D. Greenberg, D.S. Segal & B.L. Jacobs. 1985. Preclinical Psychopharmacology. Preclinical Psychopharmacology
343
363
.
Sachin N. Pradhan. (1984) Phencyclidine (PCP): Some human studies. Neuroscience & Biobehavioral Reviews 8:4, pages 493-501.
Crossref
Crossref
Chao-Yu Hu, M.S.K. Choudhuri, Ivan E. Berg, N.G.S. Rao & Arvind K. Chaturvedi. (1984) Toxicity of 1-phenylcyclohexene and its interaction with phencyclidine. Toxicology and Applied Pharmacology 76:3, pages 403-413.
Crossref
Crossref
S.C. Berry, S.L. Dawkins & D. Lodge. (2012) Comparison of s‐ and κ‐ opiate receptor ligands as excitatory amino acid antagonists. British Journal of Pharmacology 83:1, pages 179-185.
Crossref
Crossref
Arvind K. Chaturvedi & N.G.S. Rao. (1984) Influence of phencyclidine on the translocation of pentobarbital in mice. Toxicology 30:2, pages 149-155.
Crossref
Crossref
J.-E. Lindgren & B. Holmstedt. 1983. Toxicology in the Use, Misuse, and Abuse of Food, Drugs, and Chemicals. Toxicology in the Use, Misuse, and Abuse of Food, Drugs, and Chemicals
61
73
.
H. Berlet, H. Noetzel, G. Quadbeck, W. Schlote, H. P. Schmitt & Günter UleH. Berlet, G. Quadbeck & G. Ule. 1983. Pathologie des Nervensystems II. Pathologie des Nervensystems II
251
656
.
Ferris N Pitts, Robert E Allen, Orm Aniline & Rodney W Burgoyne. (1982) The Dilemma of the Toxic Psychosis: Differential Diagnosis and the PCP Psychosis. Psychiatric Annals 12:8, pages 762-768.
Crossref
Crossref